Provided by Tiger Fintech (Singapore) Pte. Ltd.

Merck

85.70
-0.2900-0.34%
Post-market: 85.750.0490+0.06%19:59 EDT
Volume:6.55M
Turnover:561.69M
Market Cap:214.06B
PE:13.21
High:86.46
Open:85.66
Low:85.24
Close:85.99
52wk High:111.58
52wk Low:73.31
Shares:2.50B
Float Shares:2.49B
Volume Ratio:0.62
T/O Rate:0.26%
Dividend:3.16
Dividend Rate:3.69%
EPS(TTM):6.49
EPS(LYR):6.76
ROE:35.42%
ROA:13.01%
PB:4.37
PE(LYR):12.68

Loading ...

FDA Approves Merck's Blockbuster Cancer Treatment Keytruda Subcutaneous Injection Formulation

Deep News
·
Sep 20

FDA approves Merck’s Keytruda Qlex for solid tumor indications

TIPRANKS
·
Sep 20

FDA: Approves Pembrolizumab and Berahyaluronidase Alfa-Pmph for Subcutaneous Injection - Website

THOMSON REUTERS
·
Sep 20

Dow Component Merck Rises 0.7% Despite Broker Downgrade

Deep News
·
Sep 19

Merck Gets Positive Opinions From Europe's CHMP on Keytruda, Enflonsia

Dow Jones
·
Sep 19

Merck's RSV Antibody Enflonsia Receives Recommendation for Approval From European Medicines Agency Committee

MT Newswires Live
·
Sep 19

Merck receives positive EU CHMP opinion for Enflonsia

TIPRANKS
·
Sep 19

Merck Receives Positive EU Chmp Opinion for Enflonsia™ (Clesrovimab) for the Prevention of Respiratory Syncytial Virus (Rsv) in Infants During Their First Rsv Season

THOMSON REUTERS
·
Sep 19

Merck Receives Two Positive EU Chmp Opinions for Keytruda® (Pembrolizumab), for Subcutaneous (Sc) Administration and for New Indication for Earlier-Stage Head and Neck Cancer

THOMSON REUTERS
·
Sep 19

Ema's Chmp: Withdrawal of Initial Marketing Authorisation Application for Iovance Biotherapeutics B.v.'s Amtagvi Medicine

THOMSON REUTERS
·
Sep 19

Ema's Chmp: Recommended Five Extensions of Indication for Medicines Bimervax, Dupixent, Keytruda

THOMSON REUTERS
·
Sep 19

Ema's Chmp: Recommended Granting Marketing Authorisation for Imaavy (Nipocalimab)

THOMSON REUTERS
·
Sep 19

Biocytogen's Antibody Empire: A Super BD Gateway

Deep News
·
Sep 19

Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr.'s CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?'

Benzinga_recent_news
·
Sep 19

Alnylam Joins Alliance for Genomic Discovery

MT Newswires Live
·
Sep 18

PDS Biotech Sets Significant Benchmark in Head and Neck Cancer by Achieving Extended Survival in Low PD-L1 Expression (CPS 1–19) Cohort in VERSATILE-002 Trial, Potentially Eliminating Need for Chemotherapy in the Population

GlobeNewswire
·
Sep 18

BIOCYTOGEN-B (02315) Technology Platform Yields Multiple Achievements, Signs Consecutive Partnerships with Merck and Tubulis to Advance International Collaboration

Stock News
·
Sep 18

Hong Kong Stocks Move | BIOCYTOGEN-B (02315) Surges Over 15% in Early Trading as STAR Market IPO Review Approaches, Company Recently Signed Antibody Licensing Deal with Merck

Stock News
·
Sep 18

Merck Cut to Hold From Buy by Berenberg

Dow Jones
·
Sep 17

Berenberg Downgrades Merck & Co. to Hold From Buy, Adjusts Price Target to $90 From $100

MT Newswires Live
·
Sep 17